| Symbol | CRDF |
|---|---|
| Name | CARDIFF ONCOLOGY, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 11055 FLINTKOTE AVENUE, SAN DIEGO, California, 92121, United States |
| Telephone | +1 858 952-7570 |
| Fax | — |
| — | |
| Website | https://www.cardiffoncology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001213037 |
| Description | Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. Additional info from NASDAQ: |
Aggarwal Ajay 🟢 acquired 400.0K shares (1 derivative) of Cardiff Oncology, Inc. (CRDF) at $1.72 Transaction Date: Apr 27, 2026 | Filing ID: 000004
Read moreCardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form 3 - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0002132312-26-000003 <b>Size:</b> 3 KB
Read moreNew Form DEFA14A - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001213037-26-000007 <b>Size:</b> 429 KB
Read moreNew Form DEF 14A - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001213037-26-000006 <b>Size:</b> 2 MB
Read moreNew Form ARS - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001213037-26-000004 <b>Size:</b> 955 KB
Read moreCardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
Read moreCardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
Read moreNew Form 3 - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001651911-26-000008 <b>Size:</b> 3 KB
Read moreNew Form 4/A - Cardiff Oncology, Inc. <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001651911-26-000006 <b>Size:</b> 5 KB
Read more